| Net Cash Provided by (Used in) Operating Activities |
$1,533,000 |
USD |
-339% |
Q1 2025 |
Q1 2025 |
| Net Cash Provided by (Used in) Financing Activities |
$766,000 |
USD |
-94% |
Q1 2025 |
Q1 2025 |
| Net Cash Provided by (Used in) Investing Activities |
$701,000 |
USD |
89% |
Q1 2025 |
Q1 2025 |
| Common Stock, Shares Authorized |
19,000,000 |
shares |
0% |
Q3 2025 |
Q3 2025 |
| Common Stock, Shares, Issued |
3,366,516 |
shares |
-0.41% |
Q3 2025 |
Q3 2025 |
| Common Stock, Par or Stated Value Per Share |
0.01 |
USD/shares |
0% |
Q3 2025 |
Q3 2025 |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect |
$1,468,000 |
USD |
-119% |
Q1 2025 |
Q1 2025 |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents |
$12,183,000 |
USD |
-31% |
Q3 2025 |
Q3 2025 |
| Deferred Tax Assets, Valuation Allowance |
$0 |
USD |
|
Q4 2024 |
FY 2024 |
| Payments to Acquire Property, Plant, and Equipment |
$28,000 |
USD |
-97% |
Q1 2025 |
Q1 2025 |
| Comprehensive Income (Loss), Net of Tax, Attributable to Parent |
$3,390,000 |
USD |
400% |
Q3 2025 |
Q3 2025 |
| Property, Plant and Equipment, Gross |
$17,738,000 |
USD |
1.4% |
Q4 2024 |
FY 2024 |
| Deferred Income Tax Expense (Benefit) |
$80,000 |
USD |
|
Q1 2025 |
Q1 2025 |
| Deferred Tax Assets, Operating Loss Carryforwards |
$574,000 |
USD |
|
Q4 2024 |
FY 2024 |
| Preferred Stock, Shares Issued |
0 |
shares |
|
Q3 2025 |
Q3 2025 |
| Preferred Stock, Shares Authorized |
1,000,000 |
shares |
0% |
Q3 2025 |
Q3 2025 |
| Unrecognized Tax Benefits |
$0 |
USD |
|
Q4 2024 |
FY 2024 |
| Additional Paid in Capital |
$33,010,000 |
USD |
2.1% |
Q3 2025 |
Q3 2025 |
| Preferred Stock, Shares Outstanding |
0 |
shares |
|
Q3 2025 |
Q3 2025 |
| Deferred Tax Assets, Net of Valuation Allowance |
$3,237,000 |
USD |
16% |
Q4 2024 |
FY 2024 |
| Interest Expense |
$9,753,000 |
USD |
10% |
Q1 2025 |
Q1 2025 |
| Preferred Stock, Par or Stated Value Per Share |
0.01 |
USD/shares |
0% |
Q3 2025 |
Q3 2025 |